ArticleValue of Glypican-3 as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma before and after Treatment. A Prospective Study
ArticleValue of Glypican-3 as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma before and after Treatment. A Prospective Study
ArticleEXPRESSION OF GLYPICAN-3(GPC-3) AND 8-HYDROXYDEOXYGUANOSINE (8-OHDG) IN CHRONIC HEPATITIS C AND RELATIONSHIP WITH HEPATOCELLULAR CARCINOMA
ArticleEXPRESSION OF GLYPICAN-3(GPC-3) AND 8-HYDROXYDEOXYGUANOSINE (8-OHDG) IN CHRONIC HEPATITIS C AND RELATIONSHIP WITH HEPATOCELLULAR CARCINOMA
ArticleRole Of Serum Glypican 3 As A Predictive Tool For Early Diagnosis Of Hepatocellular Carcinoma (HCC)
ArticleRole Of Serum Glypican 3 As A Predictive Tool For Early Diagnosis Of Hepatocellular Carcinoma (HCC)
ArticlePREDICTIVE AND DIAGNOSTIC ROLE OF CIRCULATING GOLGI PROTEIN-73 AND GLYPICAN-3 PROTEIN FOR CHRONIC VIRAL HEPATITIS ASSOCIATED HEPATOCELLULAR CARCINOMA
ArticlePREDICTIVE AND DIAGNOSTIC ROLE OF CIRCULATING GOLGI PROTEIN-73 AND GLYPICAN-3 PROTEIN FOR CHRONIC VIRAL HEPATITIS ASSOCIATED HEPATOCELLULAR CARCINOMA
ArticleSerum Level of Golgi Protein 73 as a Tumor Marker in Patients with Hepatocellular Carcinoma and Hepatitis C Virus-Related Liver Cirrhosis
ArticleSerum Level of Golgi Protein 73 as a Tumor Marker in Patients with Hepatocellular Carcinoma and Hepatitis C Virus-Related Liver Cirrhosis
ArticleStudy of Oncoprotein 24p3 as Diagnostic Marker for Hepatocellular Carcinoma on Top of Hepatitis C Virus
ArticleStudy of Oncoprotein 24p3 as Diagnostic Marker for Hepatocellular Carcinoma on Top of Hepatitis C Virus
ArticleSerum Galectin 3 Levels in Patients with Hepatocellular Carcinoma, Liver Cirrhosis and Chronic Viral Hepatitis
ArticleSerum Galectin 3 Levels in Patients with Hepatocellular Carcinoma, Liver Cirrhosis and Chronic Viral Hepatitis
ArticleStudy of Frequency of Hepatocellular Carcinoma Development after Direct Acting Antiviral Therapy in Hepatitis C Virus Patients
ArticleStudy of Frequency of Hepatocellular Carcinoma Development after Direct Acting Antiviral Therapy in Hepatitis C Virus Patients